Skip to main content

News

NEW SINGLE CAPSULE TREATMENT AKYNZEO™ NOW AVAILABLE FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN CANADA

Published on November 28, 2017

Pickering, ON (Canada) (November 28, 2017): Purdue Pharma (Canada) announce today that AKYNZEO™ (netupitant/palonosetron hydrochloride)…

Read More

David A. Pidduck Appointed President and CEO of Purdue Pharma (Canada)

Published on September 25, 2017

Pickering, Ontario, September 25, 2017/CNW/ — David A. Pidduck has been appointed as President and…

Read More

Klaria signs exclusive development, license and supply agreement with Purdue Pharma (Canada) for acute treatment of opioid overdose (KL-00514)

Published on August 9, 2017

Uppsala, Sweden and Pickering, Canada, August 9, 2017/CNW/ – Klaria AB (Klaria) (Parent Company, Klaria…

Read More

BIODELIVERY SCIENCES SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA (CANADA) FOR THE LICENSING AND DISTRIBUTION RIGHTS OF BELBUCA® IN CANADA

Published on July 12, 2017

Raleigh, North Carolina (USA) and Pickering, Ontario (CANADA), July 12, 2017/CNW/: Today, BioDelivery Sciences International…

Read More

ARCHIVE

2019
2018
2017
2016
2015
2014
2013
2012

For all media inquiries, please contact:

media@purdue.ca

↓